FDA OK's Medtronic's high-energy HF (heart failure) device:
This article was originally published in Clinica
Executive Summary
Medtronic has gained US approval to sell the latest product in its line of devices for treating heart failure (HF). The InSync Maximo cardiac resynchronisation therapy defibrillator (CRT-D) stops lethally fast heart rhythms using a combination of high-output defibrillation energy (35 joules) and what the firm claims is the industry's fastest charge times - ie the number of seconds between the time the device detects an abnormally fast rhythm and the moment it is ready to deliver defibrillation therapy.